Injective review

Reviewed

Overview

Injective is a Layer 1 blockchain built for finance, founded in 2018 by Eric Chen and Albert Chon and incubated by Binance Labs. It is built with the Cosmos SDK and is connected to other chains through IBC.

Its focus is trading: it has a built-in order book, so exchanges for spot, futures and other markets can be built easily on top of it.

How it works

  • Validators stake INJ to secure the network and earn rewards.
  • Apps on Injective (exchanges, derivatives, tokenized assets) share fees with the network.
  • Since 2025, Injective also runs an Ethereum-compatible environment (EVM), so Ethereum apps can be deployed.
  • Community BuyBack: each month, participants commit INJ; it is burned, and they receive a share of ecosystem revenue in return.

The Supply Squeeze

In January 2026, holders approved IIP-617, the “Supply Squeeze”, with almost unanimous support. It reduces new INJ issuance and speeds up burns, aiming to make INJ shrink over time. Some independent analyses argue that, at current activity, burns still don’t fully offset new staking rewards.

The INJ token

INJ at a glance
Supply (Oct 2026) 100 million INJ
Price (29 Oct 2026) about $8.09
All-time high about $52.62 (March 2024)
Market cap about $810 million (#84)

Several firms have filed for US spot INJ ETFs, but none had been approved in these sources.

Risks

  • Burns vs. issuance. Deflation depends on ecosystem revenue growing.
  • Ecosystem size. Injective’s apps are much smaller than those on Solana or Ethereum.
  • Competition. Hyperliquid, Solana and others lead in on-chain trading.

Injective vs. the competition

Injective Hyperliquid Sei
Focus Finance and trading Layer 1 Perps exchange + Layer 1 Fast trading Layer 1
Supply 100 million, burning 1 billion, buybacks Inflationary
EVM-compatible Yes Yes (HyperEVM) Yes

Our verdict

Injective has strong technology for finance, a small fixed supply and real burns. But its ecosystem is small, and burns haven’t yet turned the token deflationary in practice. INJ is a high-risk investment: invest only what you can afford to lose.

This review is for information only and is not financial advice.